A quick look at some screening data in 3 close European countries demonstrates how research subjects travel to screen concurrently at multiple different sites. Professional research subjects often travel large distances between states or countries to do so. Some travel is within the same country to different sites, but there is significant travel between countries. …
Professional research subjects cause issues with placebo rates, data quality and safety. The issue is more common than most would think. Upwards of 10% of research subjects will attempt to enroll in more than one clinical trial concurrently or before a safe and mandatory wash out period has occurred. Without a tool like Verified Clinical …
Duplicate or professional research subjects can be the silent killer of your clinical trial. The issue exists in all phases of clinical trials research, across the globe and across most therapeutic areas. As the data grows, we realize how important it is to use the Verified Clinical Trials (VCT) research subject registry to prevent these …
WHAT IF 10% of your research subjects for your clinical trial were duplicate subjects or professional research subjects, participating in other clinical trials simultaneously, not taking the study IP, providing false answers to the coordinator just to try and stay in the study, and currently in a phase 1 healthy volunteer study at the same …
Verified Clinical Trials (VCT) is excited to be conducting the First Annual European VCT Congress on 28th November in Munich, Germany. The meeting will include many of our current and future users of the VCT research subject database registry to prevent duplicate subjects in clinical trials and as well as other protocol violations. The workshop …
Verified Clinical Trials (VCT) is the global research subject database registry utilized across all phases of clinical trials research to prevent duplicate subjects and other key protocol violations. Data shows that a research subject registry will detect and prevent duplicate subjects and other protocol violations. Up to 10% in CNS clinical trials and much higher …
Your clinical trial is not meeting it’s endpoints and upon review, you detect there are duplicate subjects in your study. You and your teams spend several months trying to weed out these duplicate subjects. A new study must be performed. We hear this all the time. It occurs across most therapeutic indications and across the …
Several premier research centers in Germany have led the initiative and joined the global Verified Clinical Trials (VCT) research subject database registry to prevent duplicate subjects and other important protocol violations in an effort to improve safety and data quality in their clinical trials. Key research sites in Germany join Verified Clinical Trials to prevent …
Verified Clinical Trials (VCT) presented a poster at the ASCP meeting in Phoenix May 2019, detailing travel habits and distances specifically in CNS clinical trials. Bottom line: In many instances, research subjects travel large distances to become duplicate subjects in CNS clinical trials. A research subject database is needed to prevent duplicate subjects and many …
If you protect your computers against malware and viruses, why not protect your clinical trials from duplicate subjects that cause data quality and safety issues as well as failed clinical trials? Verified Clinical Trials (VCT) is the leading global research subject database to prevent duplicate subjects in clinical trials also known as professional research subjects. …
